Skip to main content
. 2022 Apr 26;42(Suppl 1):S20–S35. doi: 10.14639/0392-100X-suppl.1-42-2022-03

Table III.

Features of the studies using imaging techniques.

Source Year Country Study population Methods Prevalence Recovery time Topic STROBE score*
1 Altundag A 71 2020 Turkey, USA 91 cases: 24 cases COVID-19 patients, 38 patients with PIOD, and a control group of 29 patients CT scan, MRI COVID-19 patients: 100% anosmic N/A Radiological study 22
2 Kandemirli SG 72 2021 Turkey, USA 23 COVID-19 patients Sniffin’ sticks, CT scan, MRI COVID-19 patients: 100% anosmic N/A Radiological study 20
3 Lechien JR 73 2020 Multicentric 16 COVID-19 patients Validated questionnaire, Sniffin’ sticks, olfactory cleft examination, CT scan COVID-19 patients: 100% anosmic N/A Radiological study 22
4 Tekcan Sanli DE 74 2021 Turkey, USA 50 COVID-19 patients Sniffin’ sticks, CT scan. N/A N/A Radiological study 21
5 Yildirim D 75 2021 Turkey, USA 31 COVID-19 patients, 97 patients with PIOD Olfactory bulb MRI, DTI, and olfactory fMRI COVID-19 patients: 100% anosmic; PIOD patients: 18.6% hyposmic, 81.4% anosmic N/A Radiological study 21

PIOD: indicates post-infectious olfactory disorder; CT: computed tomography; MRI: magnetic resonance imaging; N/A: not applicable.

*Scores interval from 0 to 22, with higher scores showing better study quality 12.